Background: The physical function of children with cancer is reduced during treatment, which can compromise the quality of life and increase the risk of chronic medical conditions. The study, "REhabilitation, including Social and Physical activity and Education in Children and Teenagers with cancer" (Clinicaltrials.gov: NCT01772862) examines the efficacy of multimodal rehabilitation strategies introduced at cancer diagnosis. This article addresses the feasibility of and obstacles to testing physical function in children with cancer.
INTRODUCTION
Physical function testing in children with cancer is gaining increasing interest as reports of physical function impairment during and after treatment become more prevalent. Function disabilities include reductions in cardiopulmonary function, [1] [2] [3] muscle strength, [4] [5] [6] balance, 7 Abbreviations: ALL, acute lymphoblastic leukemia; CNS, central nervous system; CPET, cardiopulmonary exercise test and general physical weakness, 3, 6, 8 that impact quality of life. 3, 5, 9 The existing topic-related studies include limited numbers of children (n = 15-128) as well as restricted diagnostic groups and inclusion criteria. Furthermore, the testing methodologies during the treatment trajectory were not standardized across different studies. In particular, studies on physical function at diagnosis or at various points during initial cancer treatment are sparse, leaving it unclear when the optimal time would be for testing physical function in different cancer diagnostic groups.
A 39% reduction in cardiopulmonary function within 2 weeks of diagnosis has been reported in childhood cancer. 1 Ness et al. similarly reported that children with acute lymphoblastic leukemia (ALL) show 15% reduced lower extremity muscle strength 7-10 days after diagnosis. 4 These impairments may persist years after treatment [10] [11] [12] and result in an increased risk of chronic medical conditions, including metabolic syndrome and cardiovascular disease. [13] [14] [15] These findings suggest that preemptive measures such as exercise should be initiated from the point of diagnosis, and preliminary intervention results look promising. 16, 17 In an effort to support expanding these interventions to include a broader diagnostic group of children with cancer, this study aims to: (i) elucidate the feasibility of physical function testing during the first 3 months of treatment in children with different cancer diagnoses; (ii) compare development in physical function across cancer diagnostic groups participating in physical activity; and (iii) identify barriers to physical function testing.
METHODS

Design and setting
This study is part of the "REhabilitation, including Social and Physical activity and Education in Children and Teenagers with cancer" (RESPECT) Study (Clinical Trial registration NCT01772849 and NCT01772862); a nationwide, prospective, and controlled multiintervention program targeting children aged 6-18 years, newly diagnosed with cancer or cancer-like diseases, and treated with chemotherapy and/or radiation therapy. The RESPECT Study is imbedded in the work structure of the Center for Integrated Rehabilitation. Its multi-interventional approach was initiated to simultaneously address academic, social, and physical deficits experienced by children with cancer. 18 
Physical activity intervention components
The RESPECT study approach is described in-depth elsewhere. 18 Components of the study include introducing cancer and its treatment to classmates of the child with cancer; selecting two classmates as 'ambassadors' who take turns being co-admitted to the hospital for the day with the child with cancer (i.e. from 9 a.m. to 3 p.m.) every 14th in-and out-patient day; and conducting a supervised physical activity intervention when the child is admitted to the department of pediatric hematology and oncology that comprises individually designed activities offered three times weekly (Monday, Wednesday, and Friday). A novel approach to promoting physical activity in children with cancer is to include their ambassadors in the program. Tuesdays and Thursdays were reserved for joint sessions of the admitted children with their ambassadors. Training consisted of cardiorespiratory, strength, and balance exercises, 1 and was often camouflaged as play or games to motivate the children; and exercises were adapted daily to ensure variety in physical function. Furthermore, motivational talks were held during hospital stays that addressed ways to generally increase physical activity during treatment. 
Medical characteristics
The children were placed into four diagnostic groups (leukemia, lymphomas, extracranial solid tumors, and central nervous system [CNS] tumors).
Physical function tests
Tests conducted are described elsewhere, 18 and comprised a cardiopulmonary exercise test (CPET); timed-up-and-go; sit-to-stand; flamingo balance; and handgrip strength. The tests were performed within 14 days of diagnosis and 3 months after diagnosis ± 14 days. Data are presented as mean ± SD. n.s., not significant; NA, Not applicable.
Ambassadors were not present at testing to safeguard the child with cancer from feeling exposed or distracted. To determine testing feasibility, the two testing time points were collectively labeled 'early testing' . Inclusion criteria for participation in testing were thrombocyte count > 10 billion/l; hemoglobin count > 5 mmol/l; and temperature < 38 o . Exclusion criteria (for testing) included active diarrhea; coughing, cold; and side effects preventing participation in physical activity.
CPET was performed on an electronical brake cycle ergometer (Lode Corival Pediatric or Monark Ergomedic 839 E) using a modified Godfrey protocol. 18 The child was instructed to maintain a steady tempo (80 rpm) while the workload progressively increased by 10 W/min, to the point of exhaustion. 19 Ventilation and gas exchange data were determined breath-by-breath, using a portable INNOCOR ergo spirometry system, INNO00010 (Innovision, DK 5260 Odense, Denmark), and Hans Rudolph Valve (2-way NRBV, Hans Rudolph inc., Kansas City, MO) or Hans Rudolph mouthpiece and nose clip, if the child was fitted with a gastrointestinal tube. VO 2 peak was determined by calculating the average of the highest values continuously measured over 60 sec and was expressed in ml/kg/min) and l/min. Heart rate and oxygen saturation were measured every 30 sec (Polar FT2 sport tester Polar Electro, Kemple, Finland).
One subjective and two objective criteria were required for the CPET test to be considered valid. Subjective criteria included signs of intense effort (e.g. unsteady cycling pattern, facial flushing, unsteady breathing, or inability to maintain tempo). The objective criteria were heart rate > 180 beats/min and respiratory exchange ratio > 1.05. Flamingo balance 22 : The child was instructed to stand barefoot on one leg (preferred) for 60 sec. As the child lost balance, the timer was stopped and restarted once balance was regained. The number of restarts was recorded.
Timed-up-and-go
Handgrip strength 23 was measured using a Saehan hand dynamometer (Glanford Electronics, Scunthorpe, United Kingdom) and measured in kilograms. Two attempts per arm were performed either standing or sitting, and without using the elbow or the dynamometer touching anything. Strong verbal encouragement was given during the test and the highest score was used in the analysis.
Feasibility of physical function testing
Feasibility of the test battery was calculated using the following: (1) The percentage of eligible patients agreeing to participate in the study 
Barriers to physical function testing
Barriers to the testing were categorized as being the following: (1) Physician decision; (2) treatment-related side effect (e.g. nausea, dizziness, and/or chronic pain); (3) nonmotivation (no obvious physical reason); (4) logistical reason; (5) equipment issue; or (6) late inclusion (e.g. children experiencing a delay in fulfilling the inclusion criteria).
To further explore the potential barriers for physical function testing, the timing of chemotherapy administration was noted. The children included in the analysis were those who completed the CPET and those who did not complete the CPET due to treatment-related side effects (n = 48 at diagnosis and n = 52 at 3 months)
Ethical approval
The Regional Ethics Committee for the Capital Region 
Statistics
Analyses of the CPET, timed-up-and-go, sit-to-stand, and handgrip strength were performed using the linear mixed model to evaluate the differences in change over time between diagnostic groups (leukemia, lymphoma, extracranial solid tumors, and CNS tumors 
RESULTS
Baseline characteristics
Of the included children, 41% were diagnosed with leukemia, 28% with extracranial solid tumors, 19% with lymphomas, and 12% with CNS tumors (see Table 1 ). There were no differences in physical function between the four diagnostic groups. A trend in inferior flamingo balance scores for children with CNS tumors compared with the other three diagnostic groups was observed at diagnosis (P = 0.06) (see Table 3 ).
Feasibility of physical function testing 3.2.1 Acceptability
From January 2013 to April 2016, 75 of 78 (96%) eligible children were included in the study. None of the children who declined participation did so because of the physical activity intervention or physical function testing. Two children declined as they did not wish for their classmates to participate in the intervention and one declined, finding the intervention to be irrelevant in the out-patient setting.
Attrition: After 3 months of treatment, no child withdrew from the study. Of the enrolled children, 69 (92%) completed at least one physical function test. Of the six children who did not complete any test, two (3%) were not motivated to participate in physical function testing, despite having participated in the preceding physical activities. In four children (5.3%), testing at diagnosis and at 3 months could not be performed due to delayed (approx. 1 year) diagnosis.
Adherence: The Overall CPET completion rate was 25% (range:
19-36%), with no significant difference observed between diagnostic groups; however, the remaining test differences were observed (see Table 2 ). Children with CNS tumors completed significantly fewer tests than the other diagnostic groups (P < 0.05). Similarly, children with extracranial solid tumors completed significantly fewer sit-to-stand and timed-up-and-go tests than children with lymphoma or leukemia (P < 0.05) (see Table 2 ).
TA B L E 2
Possible tests n = 62 n = 28 n = 42 n = 18
Cardiopulmonary exercise test
Completed tests n = 16 (26%) n = 10 (36%) n = 8 (19%) n = 4 (22%)
(1) Physician decision n = 6 (10%) n = 0 n = 22 (52%) n = 0 (2) Treatment-related side effects n = 30 (48%) n = 13 (46%) n = 10 (24%) n = 9 (50%)
Timed-up-and-go
Flamingo balance
Completed tests n = 49 (80%) n = 27 (96%) n = 34 (81%) n = 6 (33%) a
(1) Physician decision n = 3 (5%) n = 0 n = 0 n = 0 (2) Treatment-related side effects n = 6 (10%) n = 0 n = 6 (14%) n = 7 (39%)
Handgrip strength (right)
Handgrip strength (left)
Completed tests n = 54 (87%) n = 27 (96%) n = 34 (81%) n = 8 (44%) a
(1) Physician decision n = 1 (2%) n = 0 n = 1 (2%) n = 0 (2) Treatment-related side effects n = 4 (6%) n = 0 n = 5 (12%) n = 5 (28%)
Completion rates were calculated using all planned tests (diagnosis tests + 3 months tests). a Significantly fewer completed tests compared with the three other diagnostic groups. b Significantly fewer completed tests compared with the lymphoma and leukemia groups.
F I G U R E 2
The influence of chemotherapy administration timing on CPET completion rates at diagnosis (A) and 3 months after (B)
Barriers to completing physical function testing
Of the 150 CPETs, 38 (25%) were completed. Six major barriers for test completion include the following: (1) Table 2 . Proximity to chemotherapy administration had a significant influence on CPET completion rates (P = 0.0004) at diagnosis, where a short timespan between the first chemotherapy and testing increased the completion rate. This was not observed after 3 months (P = 0.5) (Figure 2 ).
Impact of the initial treatment phase, including physical activity
There were no differences in supervised physical activity participation rates between diagnostic groups (P = 0.5) (see Table 1 ). After 3 months of promoting daily physical activity in the diagnostic groups, all participants maintained their baseline levels of handgrip strength (Table 3) .
CPET analysis was not performed due to low completion rates and too few paired tests (38/150, 25% completion rate). Sit-to-stand performance decreased by 24% after 3 months (P = 0.006) in the leukemia group; a significantly worse decline (P = 0.005) than in the other three groups that maintained their baseline levels. The leukemia group also showed a decrease of 24 % in timed-up-and-go performance after 3 months (P < 0.001); a significantly worse decline (P = 0.002) than in the three other groups that maintained their baseline levels. Concerning the flamingo balance test, 20% of the leukemia group faced difficulties standing on one leg for 60 sec at diagnosis and, after 3 months, 67%
had difficulties standing on one leg.
DISCUSSION
This study shows that children with cancer are generally motivated to participate in physical function testing; however, obstacles exist for different diagnostic groups. Furthermore, children diagnosed with leukemia appear to experience reduced lower extremity function, compared with the other diagnostic groups. The main barriers to test completion include physician restrictions due to tumor location that prohibit strenuous activities; treatment-related side effects; and time since last chemotherapy sessions.
In the discussion of the feasibility of physical function testing, the study shows that testing in children with cancer is possible; however, the degree of feasibility will vary according to diagnostic group and testing method, which will be elaborated in the discussion of barriers to physical function testing below. Inadequate physical function at diagnosis (e.g. neurological symptoms due to CNS tumor location and paralysis) was not an exclusion criterion in the study. As such, the study had a high participation rate, and no drop-outs. This may have influenced adherence to physical function testing; as such, the study reflects the important factor as they experience reduced cardiopulmonary function during and after treatment 1,2 and, consequently, experience an increased risk of metabolic syndrome and cardiovascular disease. [13] [14] [15] An important barrier for completing CPET was treatment-related side effects. It can be argued that these barriers could be reduced by flexible test timing, improved logistics, and communication with physicians. As shown in Figure 2A , the timing of chemotherapy administration influences the completion rates of CPET at diagnosis, suggesting that performing physical function testing prior to or in close proximity to chemotherapy administration may increase completion rates, aiming at points in time with limited occurrence of acute chemotherapyrelated side effects, for example, nausea, pain, mucositis, and fatigue.
At 3 months, however, no influence of chemotherapy administration timing was observed. This may be due to the heterogeneity of the population and treatment protocols as well as the risk of adverse effects and side effects. In addition, participants were not asked to visit the hospital solely to perform physical function tests. We experienced the optimal time for testing to be the day prior to a chemotherapy session while patients were still out-patients. Thus, further studies addressing the timing of physical function testing are warranted.
Furthermore, including different equipment options, as demonstrated by Fiuza-Luces et al., 24 may also improve CPET completion rates; for example, simultaneously using a treadmill and arm crank ergometer to perform CPET. The only drawback when using different equipment options for CPET is the limited comparability between the results.
To improve overall completion rates, it is recommended that flexible equipment options are used, as well as flexible time points-for example, prior to a chemotherapy session.
The study anticipated recruiting more children with CNS tumors as this diagnosis represents approximately 33% of all childhood cancer cases; however, the grouping in the study only represented 12%.
This ongoing limitation is related to the study's inclusion criteria, that is, children receiving chemotherapy and/or radiation therapy, and excluded children having undergone only surgery.
The median participation rate in supervised physical activities was 46%, and no difference was observed between diagnostic groups. The participation rate was at least two supervised sessions per five admitted weekdays. Yet, a significant reduction in lower extremity function was observed in the leukemia group compared with the other diagnostic groups (i.e. reduced sit-to-stand and timed-up-and-go performance). A possible explanation may be the difference in treatment protocols. Children treated for ALL, more particularly, receive several chemotherapeutic agents that impair physical function. 25 The majority of children in the leukemia group followed the NOPHO ALL 25 The cumulative effects result in both impaired peripheral nervous system function along with a catabolic state, which result in reduced muscle mass and may explain the observed reduction in lower extremity function despite the intervention. The same chemotherapeutic agents are included in other treatment protocols, however in lower dosages, intensity, and combinations. Exploring this significance in any depth is beyond the scope of this study.
A study by Hartman et al. that included 51 children with leukemia randomized into either a group with a parent-supervised homebased exercise intervention or a control group, reported significantly decreased physical function at diagnosis compared with that of healthy peers. Despite the intervention, this study showed no change over time. 30 The current study data confirm physical function reduction during intense leukemia treatment.
Other studies have shown significant improvements in physical function when interventions were initiated at the onset of ALL maintenance therapy. [31] [32] [33] [34] [35] However, the children in those studies showed markedly lower physical function baseline measures during treatment than did the children in the present study. 31, 34 In a study by Tanir and Kuguoglu, children used 8.5 sec and 6.6 sec (start of maintenance therapy and at 3 months, respectively) to complete the timed-up-and-go, compared with 3.8 and 5.0 sec (at diagnosis and at 3 months, respectively) for the children with leukemia in the present study. 31 Although methodological effects may be present, the better end-point performance scores in the current study compared with the baseline performance scores in the Tanir and Kuguoglu study may suggest that the present study's children with leukemia may have benefitted from the intervention.
STUDY STRENGTHS AND LIMITATIONS
The main limitations of the study are that it is confined to investigating the feasibility of physical function testing in a group of children with cancer receiving a physical activity intervention. The children's motivation to undergo testing could have been positively or negatively influenced by their ability to follow the effects of the intervention. The children represent a highly heterogeneous mixed-gender group, aged 6-18 years, and treated with 19 different protocols. As such, generalizability of the study results is limited. The main strength of this study is its high acceptability rate; 96% of the children participated, with no drop-outs, from an almost unselected group treated with irradiation and/or chemotherapy. The study process provides information on test completion rates and barriers for future studies that aim to include physical function testing for children with cancer.
CONCLUSION
Children with cancer are motivated to participate in physical function testing. Future studies should address diagnosis-specific obstacles and treatment-related side effects when designing physical function testing.
Children with leukemia have a different response to physical activity interventions compared with other diagnostic groups, which underscores the importance of designing physical activity interventions that consider specific diagnoses.
